SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030393
Filing Date
2019-08-08
Accepted
2019-08-08 06:50:53
Documents
49
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20190630.htm   iXBRL 10-Q 2064698
2 EX-31.1 reta-ex311_6.htm EX-31.1 20537
3 EX-31.2 reta-ex312_8.htm EX-31.2 20603
4 EX-32.1 reta-ex321_9.htm EX-32.1 10188
5 EX-32.2 reta-ex322_12.htm EX-32.2 10170
  Complete submission text file 0001564590-19-030393.txt   4913770

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA reta-20190630.xsd EX-101.SCH 30107
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20190630_cal.xml EX-101.CAL 34779
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20190630_def.xml EX-101.DEF 108867
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20190630_lab.xml EX-101.LAB 254057
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20190630_pre.xml EX-101.PRE 185414
11 EXTRACTED XBRL INSTANCE DOCUMENT reta-10q_20190630_htm.xml XML 587565
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 191007385
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences